A Clinical Study of Vasadi Ghanvati in the Management of Amlapitta w.s.r. to Hyperacidity

Authors

  • Mahesh Rameshbhai Patel
  • Ashok Pandya

Keywords:

Amlapitta, vasadighanvati, vasadi ghanvati

Abstract

Amlapitta means a condition in which sourness of Pitta gets increased. “Amlapitta” is the disease of “Annavaha Srotas”. The Nidana Sevana creates Mandagni and due to Mandagni, Ajirna is developed which leads to Annavisha production. This Annavisha mixes with Pittadi Doshas then it produces the Amlapitta disease. According to modern view, ‘Hyperacidity’ can be compared with Amlapitta. The aim of this study is to evaluate the efficacy of “vasadighanvati” in the management of Amlapitta. Total 30 patients of age group 16–60 years were registered. Assessment was done based on the relief in symptoms after 7 weeks of treatment, with a follow-up of 2 weeks. The data obtained in clinical study was analyzed by using “t” test. It was found that 6.66% had complete remission, 46.66% had marked improvement and 46.66% had moderate improvement. So, it can be concluded that drug is effective in Amlapitta without any side effect.

References

Charaka Samhita. Sutra Sthana 30/26. Commentary Chakrapanidatta. Sharma RK, editor. Bhagawandash. Varansi: Chowkhamba Sanskrita Series; 2001.

Bhavaprakasha Madhyam Khanda 10/17. Vidyotini Hindi Commentary by Pandit Shri Brahma Shankar Mishra. 11th Edn. Varansi: Chaukhambha Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Guduchyadivarga 89–90. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Guduchyadivarga 6–10. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Guduchyadivarga 91–92. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Guduchyadivarga 93–96. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Vaidya Sharma PV. Dravya Guna Vignana. 6th Adhyay. Varansi: Chaukhambha Sanskrit Series; 544–546p.

Bhava Prakasha Nighantu. Guduchyadivarga 239–241. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Haritakyadivarga 11, 27–29, 31–33. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Haritakyadivarga 36–37. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Haritakyadivarga 38–41. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Bhava Prakasha Nighantu. Shakvarga 71, 72. Hindi Commentary by Chunekara. 11th Edn. Varansi: Chaukhamba Sanskrit Series; 2007.

Downloads

Published

2017-01-06

Issue

Vol. 6 No. 1 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.